Selective expansion of memory CD4+ T cells by mitogenic human CD28 generates inflammatory cytokines and regulatory T cells

被引:15
作者
Singh, Manisha [1 ]
Basu, Sreemanti [1 ]
Camell, Christina [1 ]
Couturier, Jacob [1 ]
Nudelman, Rodolfo J. [1 ]
Medina, Miguel A. [1 ]
Rodgers, John R. [1 ]
Lewis, Dorothy E. [1 ]
机构
[1] Baylor Coll Med, Dept Immunol, Houston, TX 77030 USA
关键词
costimulation; human T cells; inflammation; regulatory T cells; T cell activation;
D O I
10.1002/eji.200737929
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Costimulatory signals are important for development of effector and regulatory T cells. In this case, CD28 signaling is usually considered inert in the absence of signaling through the TCR. By contrast, mitogenic rat CD28 mAb reportedly expand regulatory T cells without TCR stimulation. We found that a commercially available human CD28 mAb (ANC28) stimulated PBMC without TCR co-ligation or cross-linking; ANC28 selectively expanded CD4(+)CD25(-)FOXP3(-) (Teff) and CD4(+)CD25(-)FOXP3(-) (Treg) cells. ANC28 stimulated the CD45RO(+)CD4(+) (memory) population, whereas CD45RA(+)CD4(+) (naive) cells did not respond. ANC28 also induced inflammatory cytokines. Treg induced by ANC28 retain the Treg phenotype longer than costimulated Treg. Treg induced by ANC28 suppressed CD25(-) T cells through a contact-dependent mechanism. Purity influenced the response of CD4(+)CD25(+) cells because bead-purified CD4(+)CD25(+) cells (85-90% pure) responded strongly to ANC28, whereas 98% pure FACS-sorted CD4(+)CD25(bright) (Treg) did not respond. Purified CD4(+)CD25(int) cells responded similarly to the bead-purified CD4(+)CD25(+) cells. Thus, pre-activated CD4(+) T cells (CD25(int)) respond to ANC28 rather than Treg (CD25(bright)). The ability of ANC28 to expand both effectors producing inflammatory cytokines as well as suppressive regulatory T cells might be useful for ex vivo expansion of therapeutic T cells.
引用
收藏
页码:1522 / 1532
页数:11
相关论文
共 44 条
[11]   Crystal structure of a soluble CD28-Fab complex [J].
Evans, EJ ;
Esnouf, RM ;
Manso-Sancho, R ;
Gilbert, RJC ;
James, JR ;
Yu, C ;
Fennelly, JA ;
Vowles, C ;
Hanke, T ;
Walse, B ;
Hünig, T ;
Sorensen, P ;
Stuart, DI ;
Davis, SJ .
NATURE IMMUNOLOGY, 2005, 6 (03) :271-279
[12]   The CD28 signaling pathway regulates glucose metabolism [J].
Frauwirth, KA ;
Riley, JL ;
Harris, MH ;
Parry, RV ;
Rathmell, JC ;
Plas, DR ;
Elstrom, RL ;
June, CH ;
Thompson, CB .
IMMUNITY, 2002, 16 (06) :769-777
[13]   Interleukin 2 signaling is required for CD4+ regulatory T cell function [J].
Furtado, GC ;
de Lafaille, MAC ;
Kutchukhidze, N ;
Lafaille, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 196 (06) :851-857
[14]   A novel costimulatory signaling in human T lymphocytes by a splice variant of CD28 [J].
Hanawa, H ;
Ma, Y ;
Mikolajczak, SA ;
Charles, ML ;
Yoshida, T ;
Yoshida, R ;
Strathdee, CA ;
Litchfield, DW ;
Ochi, A .
BLOOD, 2002, 99 (06) :2138-2145
[15]   Features of selective kinase inhibitors [J].
Knight, ZA ;
Shokat, KM .
CHEMISTRY & BIOLOGY, 2005, 12 (06) :621-637
[16]   Transient accumulation of human mature thymocytes and regulatory T cells with CD28 superagonist in "human immune system" Rag2-/- γc-/- mice [J].
Legrand, N ;
Cupedo, T ;
van Lent, AU ;
Ebeli, MJ ;
Weijer, K ;
Hanke, T ;
Spits, H .
BLOOD, 2006, 108 (01) :238-245
[17]   Tumor necrosis factor-α and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription [J].
Lewis, DE ;
Merched-Sauvage, M ;
Goronzy, JJ ;
Weyand, CM ;
Vallejo, AN .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (28) :29130-29138
[18]   Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist [J].
Lin, CH ;
Hünig, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (03) :626-638
[19]   Polo-like kinases inhibited by Wortmannin - Labeling site and downstream effects [J].
Liu, Yongsheng ;
Jiang, Ning ;
Wu, Jiangyue ;
Dai, Wei ;
Rosenblum, Jonathan S. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (04) :2505-2511
[20]   Wortmannin, a widely used phosphoinositide 3-kinase inhibitor, also potently inhibits mammalian polo-like kinase [J].
Liu, YS ;
Shreder, KR ;
Gai, WZ ;
Corral, S ;
Ferris, DK ;
Rosenblum, JS .
CHEMISTRY & BIOLOGY, 2005, 12 (01) :99-107